About Paul Bresge
Form D filings for Ray Therapeutics from 2022 to 2023 list Paul Bresge as chief executive officer and director.
Paul Bresge first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Paul Bresge in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Paul Bresge works with at each company, as listed on that company's latest Form D.
Ray Therapeutics, Inc. · Form D, May 26, 2023
TA
Tiba Aynechi
Director
DK
Dmitry Kuzmin
Director
SA
Sean Ainsworth
Executive officer and director
RC
Raymond Camahort
Director
HC
Hannah Chang
Director
GA
Gary Abrams
Director